Clinical value STIM, Inc. provides intraoperative neurophysiological monitoring (IONM) services including EEG, MEP, SSEP, EMG and ABR to reduce iatrogenic nervous system damage, presenting a clear upsell for hospitals seeking enhanced patient safety and surgical outcomes.

Niche reach With a small team size (11-50 employees) and revenue in the lower end of enterprise scale, STIM represents an opportunity for scalable partnerships with mid-market hospitals and surgical centers that need specialized monitoring without large multi-vendor contracts.

Hospital value STIM emphasizes value to hospitals and surgeons through consistent patient safety improvements and operational guidance, suggesting sales plays around risk reduction, compliance, and surgeon satisfaction metrics.

Growth potential As a decade-long player in intraoperative monitoring, STIM could expand services into additional procedure lines or geographic markets; potential cross-sell opportunities include expanding EEG and ABR monitoring capabilities to broader surgical teams.

Tech-enabledOps Leverage STIM’s reliance on clinical neurophysiology expertise and advanced monitoring technology as a differentiator; complementary tech partnerships (data integration with hospital EMR, reporting dashboards) could streamline workflows and strengthen contract value.